Channels - Incubadoras de empresas en INTA: capacidades y resultados (2008-2022) :: Servicio de Descubrimiento de la UNA

Similar Items: Incubadoras de empresas en INTA: capacidades y resultados (2008-2022)

Author: Méndez Isla, Malena

Quick Look
Incubadoras de empresas en INTA: capacidades y resultados (2008-2022)

Author: Wigdorovitz, Andres

Quick Look
Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
Quick Look
Chicken egg yolk antibodies against bovine respiratory syncytial virus neutralize the virus in vitro
Quick Look
Minimally processed crude leaf extracts of Nicotiana benthamiana containing recombinant foot and mouth disease virus-like particles are immunogenic in mice
Quick Look
Comparison of strategies for the production of FMDV empty capsids using the Baculovirus Vector System
Quick Look
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants
Quick Look
Brucella spp. Lumazine synthase as a novel immunomodulator to produce egg yolk antibodies
Quick Look
Comparison of transient and stable expression of foot-and-mouth disease virus capsid proteins in mammalian cells
Quick Look
Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids
Quick Look
Plant‐produced viral bovine vaccines: what happened during the last 10 years?
Quick Look
Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2
Quick Look
Quantitation of cytokine gene expression by real time PCR in bovine milk and colostrum cells from cows immunized with abovine rotavirus VP6 experimental vaccine
Quick Look
The efficacy of ELISA commercial kits for the screening of equine infectious anemia virus infection = Eficacia de ensayos de ELISA comerciales para el screening de infección por el virus de la anemia infecciosa equina
Quick Look
Bovine dendritic cell activation, T cell proliferation and antibody responses to foot-and-mouth disease, is similar with inactivated virus and virus like particles
Quick Look
Foot-and-Mouth Disease: Optimization, Reproducibility, and Scalability of High-Yield Production of Virus-Like Particles for a Next-Generation Vaccine
Quick Look
Mecanismos involucrados en la duración de la respuesta inmune humoral al virus de la fiebre aftosa
Quick Look
A new passive immune strategy based on IgY antibodies as a key element to control neonatal calf diarrhea in dairy farms
Quick Look
FMD empty capsids combined with the immunostant particle adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus
Quick Look
Development of nanobodies against Mal de Río Cuarto virus major viroplasm protein P9‑1 for diagnostic sandwich ELISA and immunodetection
Quick Look
Incubadoras de empresas en INTA: capacidades y resultados (2008-2022)
Quick Look
A novel MHC-II targeted BVDV subunit vaccine induces a neutralizing immunological response in guinea pigs and cattle
Quick Look
Development of an IgY-Based treatment to control bovine Coronavirus diarrhea in dairy calves
Quick Look
Development of a platform process for the production and purification of single‐domain antibodies
Quick Look
Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
Quick Look
Passive immunity to control Bovine coronavirus diarrhea in a dairy herd in Argentina = Inmunidad pasiva en el control de la diarrea por coronavirus bovino en un rodeo lechero de Argentina